Clinical observations, such as anaphylaxis in patients with therapeutic-specific IgG antibodies but undetectable IgE, and the association of FcγRIIA polymorphisms with anaphylaxis in specific populations, further support this hypothesis [22]. This evidence concerns the gene IGHE and anaphylaxis.